莱茵生物：10月27日召开董事会会议

Group 1 - The core point of the article is that Rhine Biotech (SZ 002166) announced the cancellation of its supervisory board during its board meeting held on October 27, 2025 [1] - For the first half of 2025, Rhine Biotech's revenue composition was 98.71% from manufacturing and 1.29% from other industries [1] - As of the report date, Rhine Biotech's market capitalization was 5.8 billion yuan [1]